{"transactions":[{"id":967119,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71407,"kind":"person","name":"GLASSPOOL JOHN","position":1,"cik":"0001644079","reported_name":"GLASSPOOL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Rights","published_at":"2025-12-16T14:29:12.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":164000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026."}],"balance_after":164000,"derivative":{"exercise_price":4.06,"exercise_date":"2026-03-12","expiration_date":"2035-12-12","underlying":"Common Stock","underlying_shares":164000},"source":{"system":"sec-edgar","filing":"0001213900-25-121969","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025121969/ownership.xml","form_type":"4"}},{"id":1098992,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71407,"kind":"person","name":"GLASSPOOL JOHN","position":1,"cik":"0001644079","reported_name":"GLASSPOOL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-30T23:28:18.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 16 equal quarterly installments commencing on September 26, 2025."}],"balance_after":100000,"derivative":{"exercise_price":0.67,"exercise_date":"2025-09-26","expiration_date":"2035-06-26","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-25-059866","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390025059866/ownership.xml","form_type":"4"}},{"id":1498837,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71407,"kind":"person","name":"GLASSPOOL JOHN","position":1,"cik":"0001644079","reported_name":"GLASSPOOL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T01:24:26.000Z","date":"2024-05-24","kind":"other","planned":false,"acquired":false,"shares":20976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer."}],"balance_after":31522,"derivative":{"exercise_price":2.48,"exercise_date":"2024-03-15","expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":20976},"source":{"system":"sec-edgar","filing":"0001213900-24-047636","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390024047636/ownership.xml","form_type":"4"}},{"id":1498836,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71407,"kind":"person","name":"GLASSPOOL JOHN","position":1,"cik":"0001644079","reported_name":"GLASSPOOL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-30T01:24:26.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":20976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the \"December Award\"), the Reporting Person became entitled to receive options for up to 20,976 additional shares of the Issuer's Common Stock on the same terms as the December Award (the \"Additional Award Shares\") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the \"Plan\"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares."}],"balance_after":52498,"derivative":{"exercise_price":2.48,"exercise_date":"2024-03-15","expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":20976},"source":{"system":"sec-edgar","filing":"0001213900-24-047636","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390024047636/ownership.xml","form_type":"4"}},{"id":1704383,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71407,"kind":"person","name":"GLASSPOOL JOHN","position":1,"cik":"0001644079","reported_name":"GLASSPOOL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-12-19T22:27:59.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":31522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 15, 2024."}],"balance_after":31522,"derivative":{"exercise_price":2.48,"exercise_date":"2024-03-15","expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":31522},"source":{"system":"sec-edgar","filing":"0001213900-23-097028","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390023097028/ownership.xml","form_type":"4"}},{"id":1874289,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71407,"kind":"person","name":"GLASSPOOL JOHN","position":1,"cik":"0001644079","reported_name":"GLASSPOOL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-30T21:08:06.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":92958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of the Company on December 16, 2022, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan, as amended (the \"Plan\"), increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2023, at the 2023 Annual Meeting of the Company's shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 equal quarterly installments commencing on March 16, 2023."}],"balance_after":150000,"derivative":{"exercise_price":3.37,"exercise_date":"2023-03-16","expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":92958},"source":{"system":"sec-edgar","filing":"0001213900-23-044084","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390023044084/ownership.xml","form_type":"4"}},{"id":2079460,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71407,"kind":"person","name":"GLASSPOOL JOHN","position":1,"cik":"0001644079","reported_name":"GLASSPOOL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-12-20T22:32:05.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":57042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 16, 2023."}],"balance_after":57042,"derivative":{"exercise_price":3.37,"exercise_date":"2023-03-16","expiration_date":"2032-12-16","underlying":"Common Stock","underlying_shares":57042},"source":{"system":"sec-edgar","filing":"0001213900-22-081475","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390022081475/ownership.xml","form_type":"4"}},{"id":2254905,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71407,"kind":"person","name":"GLASSPOOL JOHN","position":1,"cik":"0001644079","reported_name":"GLASSPOOL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-26T22:41:52.000Z","date":"2022-05-25","kind":"grant","acquired":true,"shares":91235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Board of Directors of the Company on December 17, 2021, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan (the \"Plan\") increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2022, at the 2022 Annual Meeting of the Company's shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 equal quarterly installments, at 6.25% per quarter, commencing on March 17, 2022."}],"balance_after":150000,"derivative":{"exercise_price":19.03,"exercise_date":"2022-03-17","expiration_date":"2031-12-17","underlying":"Common Stock","underlying_shares":91235},"source":{"system":"sec-edgar","filing":"0001213900-22-029835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390022029835/ownership.xml","form_type":"4"}},{"id":2462122,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71407,"kind":"person","name":"GLASSPOOL JOHN","position":1,"cik":"0001644079","reported_name":"GLASSPOOL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-22T02:31:13.000Z","date":"2021-12-17","kind":"grant","acquired":true,"shares":58765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 equal quarterly installments commencing on March 17, 2022."}],"balance_after":58765,"derivative":{"exercise_price":19.03,"exercise_date":"2022-03-17","expiration_date":"2031-12-17","underlying":"Common Stock","underlying_shares":58765},"source":{"system":"sec-edgar","filing":"0001213900-21-066824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390021066824/ownership.xml","form_type":"4"}},{"id":2910510,"issuer":{"id":5498,"kind":"organization","name":"RELMADA THERAPEUTICS, INC.","symbol":"RLMD"},"owners":[{"id":71407,"kind":"person","name":"GLASSPOOL JOHN","position":1,"cik":"0001644079","reported_name":"GLASSPOOL JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-01-11T21:09:27.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest from the date of grant in quarterly increments of 6.25%."}],"balance_after":100000,"derivative":{"exercise_price":33.43,"exercise_date":"2021-04-07","expiration_date":"2031-01-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-21-001426","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553643/000121390021001426/ownership.xml","form_type":"4"}}]}